# Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients

> **NCT05666219** · PHASE4 · WITHDRAWN · sponsor: **National Institute of Cardiovascular Diseases, Pakistan**

## Conditions studied

- Complete Heart Block
- Inferior Wall Myocardial Infarction

## Interventions

- **DRUG:** Aminophylline Injection

## Key facts

- **NCT ID:** NCT05666219
- **Lead sponsor:** National Institute of Cardiovascular Diseases, Pakistan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-12-19
- **Primary completion:** 2023-12-18
- **Final completion:** 2025-01-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** we could not find patients fulfilling all of our inclusion criteria
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05666219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05666219, "Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05666219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*